Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
Clinical trial NCT03009396 · COMPLETED
Trial details
- NCT number
- NCT03009396
- Sponsor
- RedHill Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-18
- Primary completion
- 2018-11-13
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.